Financhill
Sell
27

SCPH Quote, Financials, Valuation and Earnings

Last price:
$3.85
Seasonality move :
15.21%
Day range:
$3.82 - $3.99
52-week range:
$1.94 - $5.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.44x
P/B ratio:
10.87x
Volume:
688.1K
Avg. volume:
398.9K
1-year change:
-11.44%
Market cap:
$204.3M
Revenue:
$36.3M
EPS (TTM):
-$1.91

Earnings Data

Next earnings date for SCPH
Aug 14
2025
Most recent earnings per share
-$0.37
Missed by $0.09
(May 14/2025)
Consensus Estimate
-$0.29
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SCPH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/14/2025 Q2 $15.4M -- -- -$0.30 --
05/14/2025 Q1 $11.6M $11.8M -$0.37 -$0.29 -$0.09
03/19/2025 Q4 $12.2M $12.2M -$0.35 -$0.39 $0.04
11/13/2024 Q3 $10.8M $10M -$0.75 -$0.30 -$0.45
08/14/2024 Q2 $8M $8.1M -$0.44 -$0.41 -$0.03
05/14/2024 Q1 $6M $6.1M -$0.36 -$0.43 $0.07
03/13/2024 Q4 $5.8M $6.1M -$0.35 -$0.41 $0.06
11/08/2023 Q3 -- -- -$0.41 -$0.37 -$0.04
08/10/2023 Q2 -- -- -$0.36 -$0.38 $0.02
05/10/2023 Q1 -- -- -$0.30 -$0.38 $0.08
03/22/2023 Q4 -- -- -$0.30 -$0.39 $0.09
11/09/2022 Q3 -- -- -$0.37 -$0.41 $0.04
08/09/2022 Q2 -- -- -$0.35 -$0.32 -$0.03
05/16/2022 Q1 -- -- -$0.28 -$0.29 $0.01
03/22/2022 Q4 -- -- -$0.27 -$0.34 $0.07
11/09/2021 Q3 -- -- -$0.24 -$0.32 $0.08
08/11/2021 Q2 -- -- -$0.26 -$0.30 $0.04
05/12/2021 Q1 -- -- -$0.26 -$0.30 $0.04
03/23/2021 Q4 -- -- -$0.28 -$0.37 $0.09
11/16/2020 Q3 -- -- -$0.33 -$0.37 $0.04
08/13/2020 Q2 -- -- -$0.36 -$0.42 $0.06
05/12/2020 Q1 -- -- -$0.35 -$0.54 $0.19
03/24/2020 Q4 -- -- -$0.58 -$0.52 -$0.06
11/12/2019 Q3 -- -- -$0.33 -$0.42 $0.09
08/07/2019 Q2 -- -- -$0.39 -$0.49 $0.10
05/08/2019 Q1 -- -- -$0.47 -$0.49 $0.02
03/21/2019 Q4 -- -- -$0.27 -$0.45 $0.18
11/13/2018 Q3 -- -- -$0.31 -$0.54 $0.23
08/14/2018 Q2 -- -- -$0.53 -$0.57 $0.03
05/07/2018 Q1 -- -- -$0.47 -$0.50 $0.03
03/20/2018 Q4 -- -- -$0.46 -$0.51 $0.05

scPharmaceuticals Earnings Questions

  • How Much did scPharmaceuticals Generate in Revenue Last Quarter?

    scPharmaceuticals reported $11.8M worth of top line sales in its most recent quarter.

  • Did scPharmaceuticals Beat Earnings Last Quarter?

    scPharmaceuticals announced earnings per share of -$0.37 which represents a miss of analyst forecast a -$0.29 per share.

  • Is scPharmaceuticals Profitable?

    scPharmaceuticals reported $8.3M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for scPharmaceuticals EPS Next Year?

    scPharmaceuticals's earnings are forecast to decrease from -$1.91 per share to -$1.01 per share next year representing a decrease of -47.02%.

  • When is scPharmaceuticals's Earnings Date?

    scPharmaceuticals's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SoFi Stock a Buy Under $20?
Is SoFi Stock a Buy Under $20?

After briefly flirting with penny‑stock territory during the 2022 bear…

Why Is Apple Stock Not Joining the Broader Market Rally?
Why Is Apple Stock Not Joining the Broader Market Rally?

The S&P 500 has sprinted 4.92% higher so far in…

Will Google Stock Double by 2030?
Will Google Stock Double by 2030?

If you bought Alphabet (NASDAQ: GOOGL) when Gmail launched in…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 54x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
49
NKE alert for Jun 28

Nike [NKE] is up 15.29% over the past day.

Buy
81
KTOS alert for Jun 28

Kratos Defense & Security Solutions [KTOS] is up 10.89% over the past day.

Sell
44
GDXU alert for Jun 28

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 10.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock